Please use this identifier to cite or link to this item:
|Title:||Donepezil hydrochloride in the treatment of senile Alzheimer's disease, early stage|
|Publisher:||Kharkiv National Medical University|
|Citation:||Berezhna A. V. Donepezil hydrochloride in the treatment of senile Alzheimer's disease, early stage / A. V. Berezhna, E. K. Reznichenko, O. S. Pavlova // 7th International Scientific Interdisciplinary Conference (ISIC) for medical students and young scientists, Kharkiv, May 15-16, 2014 : abstract book / KhNMU. – Kharkiv, 2014. – P. 226.|
|Abstract:||We observed five patients aged 75 to 82 years, two women and three men. Memory loss, impaired concentration, mild depression was observed in all patients. Based on clinical and paraclinical methods was diagnosed Senile Alzheimer's disease early stage. In the combined therapy was appointed donepezil hydrochloride ("Alzepil") at a dose of 5 mg at bedtime for 3 months.|
|Appears in Collections:||Наукові роботи молодих вчених. Кафедра неврології № 1|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.